CAR-T treatment in myeloma

CAR-T cell treatment is a new type of immunotherapy which involves modifying and using patients’ own immune cells to treat myeloma. This animation describes what CAR-T cell treatment is, and the different stages involved in the treatment process.

Use Case

Type

Source

  • Myeloma UK

You might also like

  • Immunotherapy in myeloma

    This animation explains how the immune system functions and demonstrates its potential in treating myeloma.

    Myeloma UK Animation
  • Proteasome inhibitors in myeloma

    Proteasome inhibitor drugs, such as bortezomib (Velcade®), carfilzomib (Kyprolis®), and ixazomib (Ninlaro®), are crucial in treating myeloma. This animation explains their mechanisms and effectiveness in combating the disease.

    Myeloma UK Animation
  • High Dose Therapy and Autologous stem cell transplantation

    High-dose therapy and autologous stem cell transplantation is the standard treatment for younger or fitter myeloma patients. This animation outlines the stages of the procedure and the principles guiding each step.

    Myeloma UK Animation